Jefferies Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10M | Sell |
578,205
-21,050
| -4% | -$364K | 0.08% | 117 |
|
|
2025
Q1 | $13.1M | Buy |
599,255
+257,894
| +76% | +$5.64M | 0.12% | 77 |
|
|
2024
Q4 | $10.9M | Buy |
341,361
+292,850
| +604% | +$9.34M | 0.07% | 141 |
|
|
2024
Q3 | $1.4M | Buy |
48,511
+47,875
| +7,528% | +$1.38M | 0.01% | 503 |
|
|
2024
Q2 | $24.4K | Hold |
636
| – | – | ﹤0.01% | 1061 |
|
|
2024
Q1 | $37.4K | Sell |
636
-21,908
| -97% | -$1.29M | ﹤0.01% | 1167 |
|
|
2023
Q4 | $1.35M | Buy |
22,544
+18,236
| +423% | +$1.09M | 0.01% | 561 |
|
|
2023
Q3 | $164K | Sell |
4,308
-12,892
| -75% | -$490K | ﹤0.01% | 958 |
|
|
2023
Q2 | $1.57M | Buy |
17,200
+14,725
| +595% | +$1.34M | 0.01% | 456 |
|
|
2023
Q1 | $163K | Buy |
+2,475
| New | +$163K | ﹤0.01% | 963 |
|